ARCHIVES

Risk-Benefit Analysis Advised Prior To Hormone Therapy

This article is from The Cancer Letter archive.

Vol. 33 No. 8 | August 27, 2010

Download PDF Visit The Full Archive

Related Articles

Clinical Trials Approved By NCI In November

December 28, 2001

NCI Says Review Group Will Read Blueprint, Evaluate NCI Research

January 16, 1998

In Brief: Landers Needles Pauling on Vitamin C Study Results; David Goldenberg Heads N.J. Center

October 21, 1983

New ACR Mammography Guidelines Suggest Annual Screening For Women Age 40-50

November 12, 1982

$14.7 Million Earmark Of NCI funds Trigger Protest By Advocates, Scientists

October 24, 1996

Patients Prefer Silicone Over Saline Implants

November 26, 2010